Skip to main content

Home/ Dr. Goodyear/ Contents contributed and discussions participated by Nathan Goodyear

Contents contributed and discussions participated by Nathan Goodyear

Nathan Goodyear

Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation - 0 views

  •  
    Oxidative Stress
Nathan Goodyear

Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observa... - 0 views

  •  
    new study looked at 3 cohorts of Testosterone therapy in men.  The active cohorts found not increased risk of Prostate cancer in men with testosterone therapy at 5 years.
Nathan Goodyear

Effects of testosterone administration on cognitive function in hys... - PubMed - NCBI - 0 views

  •  
    Testosterone therapy in women post-hysterectomy, with low total and low free Testosterone, provides no benefit in cognitive function.
Nathan Goodyear

Testosterone and benign prostatic hyperplasia Jarvis TR, Chughtai B, Kaplan SA, - Asian... - 0 views

  • The prevalence of hypogonadism (often defined as serum testosterone < 300 ng dl−1 ) ranges from 6% [10] to as high as 38%
  • The process of BPH, however, continues as men age and despite the fact their serum testosterone decreases
  • Liu et al. [12] demonstrated that in a group of older males (mean age 59.8 years) that there was not a significant correlation of serum testosterone levels (total, free or bioavailable) with either prostate volume or International Prostate Symptom Score (IPSS)
  • ...11 more annotations...
  • in eugonadal men, studies have demonstrated that the prostate can increase in volume by approximately 12%
  • There seems to be little doubt that the treatment with testosterone of a young hypogonadal male leads to significant growth of the prostate
  • Behre et al. [22] demonstrated increased prostate volume and prostate-specific antigen (PSA) levels in hypogonadal men
  • Most studies, however, have shown no effect of exogenous androgens on PSA or prostate volume for older hypogonadal males
  • They argue that the prostate is relatively insensitive to changes in androgen concentration at normal levels or in mild hypogonadism because the AR is saturated by androgens and therefore maximal androgen-AR binding is achieved. Conversely, the prostate is very sensitive to changes in androgen levels when testosterone is low
  • saturation model
  • visceral obesity (one of the most significant components of metabolic syndrome) is associated with prostate volume and influences prostate growth during TRT.
  • This hypothesis of inflammation induced LUTS is also argued to be a mechanism for improvement of LUTS with PDE5I
  • The concept, therefore, that treatment with TRT of hypogonadal males with metabolic syndrome might lead to improvement/stabilization of their LUTS, appears to be confirmed in recent work by Francomano et al.
  • There was also an improvement in components of the patient's metabolic syndrome (such as BMI, waist circumference, hemoglobin A1c [HbA1c], insulin sensitivity, and lipid profile) as well as inflammatory markers and C-reactive protein.
  • They concluded that TRT was safe in this group of men, and hypothesize that TRT mitigates the pro-inflammatory factors associated with metabolic syndrome.
  •  
    Authors review the literature behind Testosterone and BPH.  The authors highlight the 4 proposed theories behind BPH: Testosterone, Estrogen, inflammation, and metabolic.   The conclusion is mixed: pointing out that no high level of evidence exists on either side of the debate of Testosterone and BPH.
Nathan Goodyear

Testosterone deficiency and cardiovascular mortality Morgentaler A, - Asian J Androl - 0 views

  • overall mortality and CV mortality were inversely associated with serum T concentrations.
  • men with low serum T, defined as < 8.7 nmol l−1 (250 ng dl−1 ), demonstrated significantly greater all-cause mortality than men with higher serum T (hazard ratio [HR]: 2.24; 95% CI: 1.41-3.57), as well as greater CV mortality
  • lower T levels were significantly associated with the presence of any CV disease
  • ...19 more annotations...
  • more than 30 years of studies suggesting that low levels of T represent an increased risk for CV and overall mortality,
  • lower serum T concentrations also are associated with CV disease, including incident coronary artery disease [17],[18],[19] and atherosclerosis,
  • the actual rate of adverse events was only half as great in the T group (123 events in 1223 men at risk = 10.1%) as in the untreated group (1587 events in 7486 men = 21.2%)
  • The study by Vigen et al. [7] has already undergone two published corrections,
  • 29 medical societies have called for retraction of the article, asserting "gross data mismanagement and contamination," that rendered the study "no longer credible
  • Mortality in T-treated men was reduced by approximately half in treated men compared with untreated men, at 10.3% versus 20.7%, respectively
  • The mortality rate for men who received TTh was 3.4 deaths per 100 person-years, and 5.7 deaths per 100 person-years in untreated men
  • HR of 0.61 (95%CI: 0.42-0.88; P = 0.008), indicating a significant reduction in mortality with TTh
  • men in the highest prognostic MI risk quartile, treatment with TTh was associated with reduced risk
  • tripling in T prescriptions in the US over the last decade
  • a majority of observational studies have found that low endogenous serum T levels are associated with increased mortality.
  • Men who received TTh were able to exercise significantly longer without ischemia compared with men who received placebo
  • In men with congestive heart failure, those who received T demonstrated greater walking distance and other functional endpoints compared with those who received placebo
  • TTh has been shown uniformly and repeatedly to improve several known CV risk factors, including reduced fat mass, body fat percent, and waist circumference, and increased lean mass
  • improved glycemic control
  • reductions in insulin resistance.
  • the evidence strongly points to improved CV status with normal serum T or treatment with TTh in men with TD
  • analysis of health insurance claims data that reported a 36% increased rate of nonfatal MI in the 90d following receipt of a T prescription compared with the 12 prior months.
  • Comparison with men who received a prescription for a phosphodiesterase type 5 inhibitor (PDE5i) revealed no increased rate of MI following the prescription
  •  
    Great review by Morgentaler of Testosterone and CVD.  He highlights the significant flaws in the JAMA and the NEJM articles of Testosterone therapy risks.  Morgentaler highlights the significant evidence that points to low T and increased risk of CVD. On contention I have, is Morgantaler seems to flip aside the massive uptick of Testosterone use in the US as compared to other countries.  The evidence definitely points to Testosterone therapy as being safe in those with low T, but there is definitely a problem of significant Testosterone doping that is taking place as well.
Nathan Goodyear

Inflammation and Native American medicine: the role of botanicals - 0 views

  •  
    review of medicinal botanicals used by native Americans.
Nathan Goodyear

Resistance exercise training improves heart rate variability and mu... - PubMed - NCBI - 0 views

  •  
    High repetition, low weight is associated with improved Heart rate variability, muscle strength and endurance in non-healthy-CAD patients.
Nathan Goodyear

Recovery from endurance exercise. - PubMed - NCBI - 0 views

  •  
    Carbohydrates required to restore muscle/liver glycogen stores.  This older article, abstract available, points to 8-10 grams of carbohydrates/kg body weight.  Though repletion of glycogen stores can occur, recovery of muscle performance may require longer time.  Studies have point to 4-6 days.
Nathan Goodyear

Reverse T3 as a parameter of myocardial function impairment in heart failure. - 0 views

  •  
    reverse T3 and the free T3:rT3 can be used to assess prognosis of those with CHF.
Nathan Goodyear

Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling: Endocri... - 0 views

  • From a broad perspective, this paradigm can be seen as an example of how hormones are activated or inactivated in a controlled fashion in specific extraglandular tissues, in an analogous role to 5α-reductase and P450 aromatase in sex steroid metabolism and to 11β-hydroxysteroid dehydrogenase in glucocorticoid metabolism.
  •  
    better source for previous post on thyroid metabolism and deiodinase.
Nathan Goodyear

http://www.neuroanatomy.wisc.edu/coursebook/neuro2(2).pdf - 0 views

  •  
    everything one wants to know on hypothalamus
Nathan Goodyear

Testosterone Supplementation Therapy in the Treatment of Patients With Metabolic Syndro... - 0 views

  •  
    Only abstract available.  Review of literature of Testosterone in men with Metabolic Syndrome.
Nathan Goodyear

Weekly Versus Monthly Testosterone Administration on Fast and Slow ... - PubMed - NCBI - 0 views

  •  
    Weekly Testosterone injections increase type 1 slow muscle fibers more than type II fast twitch muscle fibers compared to monthly injections.  The study looked at older men with sarcopenia and low T.
Nathan Goodyear

Race differences in obesity and its relationship to the sex hormone milieu : Hormone Mo... - 0 views

  • increased abdominal and visceral adipose tissue (VAT) – found in women and marked by low sex hormone binding globulin (SHBG) and high bioavailable testosterone (BT) – is related to the metabolic risk profile
  • In men, increased BT is related to decreased abdominal obesity and a decrease in the metabolic risk profile
  •  
    Only abstract available here.  Race (black vs white) is associated with changes in obesity effects on adrogenicity, particularly in women.  One wonders if this is a result of other variables i.e.vitamin D.
Nathan Goodyear

Testosterone Treatment of Men With Mild Cognitive Impairment and Lo... - PubMed - NCBI - 0 views

  •  
    small study finds limited improvement in cognition in men with low T and mild Cognitive impairment.  Little application from this study.
Nathan Goodyear

Testosterone Supplementation Improves Carbohydrate and Lipid Metabolism in Some Older M... - 0 views

  •  
    In some men, Testosterone therapy (10 mg transdermal) is associated with adipose tissue.  In those with a decrease in adipose tissue, a decrease in LDL, decrease in Triglycerides, increase in insulin sensitivity, and lower HDL were found.
Nathan Goodyear

Age, Insulin Requirements, Waist Circumference, and Triglycerides P... - PubMed - NCBI - 0 views

  •  
    Study looked at low T in men with type 1 Diabetes.  Only abstract available here.  Study finds appx 10% prevalence with age, waist circumference and insulin requirements as predictive of low T in men with type 1 Diabetes.
Nathan Goodyear

Low incidence of new biochemical hypogonadism after intensity modul... - PubMed - NCBI - 0 views

  •  
    Radiation for prostate cancer associated with decline in serum Total Testosterone at 6 months, which resolved at 12 months.
Nathan Goodyear

http://press.endocrine.org/doi/pdf/10.1210/jc.2014-1725 - 0 views

  •  
    New study finds "modest" association between Testosterone, DHEA, and FSH with libido, masturbation, and climax in women.  The author describes them as "subtle".  The association was not statistically significant.  The study found a great association with relationships than with Testosterone. This study points out the complexity that is libido in women.  It also casts doubt on the massive Testosterone push in women with little documented data.
Nathan Goodyear

Deiodinases - National Academy of HypothyroidismNational Academy of Hypothyroidism - 0 views

  •  
    Great review of thyroid metabolism.
« First ‹ Previous 5921 - 5940 of 11012 Next › Last »
Showing 20 items per page